Grants and Contributions:

Back to search
Agreement Number:
-
Agreement Value:
$160,000.00
Agreement Date:
Oct 1, 2012 - Sep 30, 2013
Description:
Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer
Organization:
Canadian Institutes of Health Research
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
236-2012-2013-Q1-00252
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:

Grant or Award spanning more than one fiscal year.
(2012-13 to 2013-14)

Recipient's Legal Name:
LI, Shyh-Dar
Research Organization:
Ontario Institute for Cancer Research (Toronto, Ontario)